In what is being seen as another gain in India's vaccine manufacturing sector, the World Health Organisation on Friday issued an emergency use listing for anti-Covid vaccine Covovax. The latter is produced by the Serum Institute of India under licence from Novavax. With the new approval, WHO is expanding the basket of jabs validated by the global health body against the viral disease.